NCT05285696View on ClinicalTrials.gov

Study to Evaluate the Safety and Dosimetry of [68Ga]-NOTA-hGZP (CSB-111) PET Imaging in Healthy Human Volunteers.

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

April 1, 2023

Study Completion Date

May 20, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

CSB-111

\[68Ga\]-NOTA-hGZP is a PET imaging agent.

Trial Locations (1)

35294

University of Alabama at Birmingham, Birmingham

Sponsors
All Listed Sponsors
collaborator

University of Alabama at Birmingham

OTHER

lead

Cytosite Biopharma Inc.

INDUSTRY

NCT05285696 - Study to Evaluate the Safety and Dosimetry of [68Ga]-NOTA-hGZP (CSB-111) PET Imaging in Healthy Human Volunteers. | Biotech Hunter | Biotech Hunter